Search research articles
Contact Us
Filters
Showing results (121-130 of 139) with videos related to
Page
of 14
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 3, 2015
Chimeric MicroRNA-1291 Biosynthesized Efficiently in Escherichia coli Is Effective to Reduce Target Gene Expression in Human Carcinoma Cells and Improve Chemosensitivity
Mei-Mei Li, Balasubrahmanyam Addepalli, Mei-Juan Tu, et al.
Biomaterials
|
May 5, 2019
Creatine based polymer for codelivery of bioengineered MicroRNA and chemodrugs against breast cancer lung metastasis
Jieni Xu, Jingjing Sun, Pui Yan Ho, et al.
Cancer Letters
|
November 4, 2018
Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models
Mei-Juan Tu, Pui Yan Ho, Qian-Yu Zhang, et al.
Placenta
|
March 16, 2017
Down-regulation of the placental BCRP/ABCG2 transporter in response to hypoxia signaling
Lissa N Francois, Ludwik Gorczyca, Jianyao Du, et al.
Journal of Lipid Research
|
November 3, 2005
Regulation of bile acid biosynthesis by hepatocyte nuclear factor 4alpha
Yusuke Inoue, Ai-Ming Yu, Sun Hee Yim, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 25, 2026
Metabolomics-based predictive biomarker discovery for thiopurine response in Crohn disease: Plasma histidine as a promising biomarker
Sum-Yuet Chan, Kang Chao, Ting Yang, et al.
Theranostics
|
March 23, 2021
<i>In vivo</i> fermentation production of humanized noncoding RNAs carrying payload miRNAs for targeted anticancer therapy
Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, et al.
Cancer Research Communications
|
October 23, 2024
PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer Cells
Zachary A Schaaf, Shu Ning, Amy R Leslie, et al.
Frontiers in Oncology
|
March 13, 2020
The Optimal Outcome of Suppressing Ewing Sarcoma Growth <i>in vivo</i> With Biocompatible Bioengineered miR-34a-5p Prodrug
Dai-Feng Li, Ying Yuan, Mei-Juan Tu, et al.
Molecular Cancer Therapeutics
|
August 5, 2022
Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment
Shu Ning, Chengfei Liu, Wei Lou, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 139) with videos related to
Sort By:
Page
of 14
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 3, 2015
Chimeric MicroRNA-1291 Biosynthesized Efficiently in Escherichia coli Is Effective to Reduce Target Gene Expression in Human Carcinoma Cells and Improve Chemosensitivity
Mei-Mei Li, Balasubrahmanyam Addepalli, Mei-Juan Tu, et al.
Biomaterials
|
May 5, 2019
Creatine based polymer for codelivery of bioengineered MicroRNA and chemodrugs against breast cancer lung metastasis
Jieni Xu, Jingjing Sun, Pui Yan Ho, et al.
Cancer Letters
|
November 4, 2018
Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models
Mei-Juan Tu, Pui Yan Ho, Qian-Yu Zhang, et al.
Placenta
|
March 16, 2017
Down-regulation of the placental BCRP/ABCG2 transporter in response to hypoxia signaling
Lissa N Francois, Ludwik Gorczyca, Jianyao Du, et al.
Journal of Lipid Research
|
November 3, 2005
Regulation of bile acid biosynthesis by hepatocyte nuclear factor 4alpha
Yusuke Inoue, Ai-Ming Yu, Sun Hee Yim, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 25, 2026
Metabolomics-based predictive biomarker discovery for thiopurine response in Crohn disease: Plasma histidine as a promising biomarker
Sum-Yuet Chan, Kang Chao, Ting Yang, et al.
Theranostics
|
March 23, 2021
<i>In vivo</i> fermentation production of humanized noncoding RNAs carrying payload miRNAs for targeted anticancer therapy
Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, et al.
Cancer Research Communications
|
October 23, 2024
PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer Cells
Zachary A Schaaf, Shu Ning, Amy R Leslie, et al.
Frontiers in Oncology
|
March 13, 2020
The Optimal Outcome of Suppressing Ewing Sarcoma Growth <i>in vivo</i> With Biocompatible Bioengineered miR-34a-5p Prodrug
Dai-Feng Li, Ying Yuan, Mei-Juan Tu, et al.
Molecular Cancer Therapeutics
|
August 5, 2022
Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment
Shu Ning, Chengfei Liu, Wei Lou, et al.
Page
of 14